Ekso Bionics Holdings, Inc.

Total Valuation

Ekso Bionics Holdings, Inc. carries a market capitalization of 28.63M, placing it among publicly traded companies globally. Its enterprise value stands at 33.65M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Ekso Bionics Holdings, Inc. currently has 3.56M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 2.57, and the price-to-book ratio stands at -0.11.

Enterprise Valuation

Financial Position

Ekso Bionics Holdings, Inc. maintains a current ratio of 1.55, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 75.21, indicating elevated leverage, while an interest coverage ratio of -36.36 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Stock Price Statistics

Ekso Bionics Holdings, Inc.'s stock has gained approximately 205.69948% over the past 52 weeks. The 50-day moving average sits at 10.62, while the 200-day moving average is 6.93.

Income Statement

Over the trailing twelve months, Ekso Bionics Holdings, Inc. generated 11.57M in revenue and converted that into -15.69M in net income, yielding earnings per share of -5.63. EBITDA reached -13.85M, while operating income came in at -15.50M.

Balance Sheet

Ekso Bionics Holdings, Inc. holds 3.99M in cash and equivalents against 4.32M in total debt, resulting in a net debt position of -148,000.00. Total book value stands at -269.24M, with working capital of 4.96M providing operational flexibility.

Cash Flow

Ekso Bionics Holdings, Inc. produced -11.96M in operating cash flow over the past twelve months. After subtracting -178,000.00 in capital expenditures, free cash flow totaled -12.14M - equivalent to -4.36 per share.

Margins

Ekso Bionics Holdings, Inc. operates with a gross margin of 52.86, reflecting its pricing power and cost economics. The operating margin of -134.06 and net profit margin of -135.66 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Ekso Bionics Holdings, Inc.'s most recent stock split took place on June 2, 2025 with a 15:1 split ratio.

Scores

Ekso Bionics Holdings, Inc. posts an Altman Z-Score of -24.68, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.